Quality Level
usage
sufficient for 50 reactions (1 mL), sufficient for 500 reactions (100 μL)
shipped in
wet ice
storage temp.
2-8°C
Gene Information
human ... NAGLU(4669)
Application
该试剂盒可在细胞溶解液、组织匀浆或纯化酶等样品中方便、快速地检测β-N-乙酰氨基葡萄糖苷酶。它是一种理想的分离细胞/组织样品溶酶体检测工具。
Biochem/physiol Actions
哺乳类动物体内的N-乙酰-D-氨基葡萄糖苷酶 (NAG) 是一种参与胞内糖脂和糖蛋白降解的溶酶体酶。在人类肾脏、肺和肝脏溶酶体中都已检测到高活性的NAG。血清NAG水平升高与某些癌症有关。
Analysis Note
该试剂盒的检测原理为NAG（NP-GLcNAc）底物在酶促作用下水解。酶水解底物后，释放出对硝基苯胺离子。然后在405 nm处采用比色法测定反应产物。
Still not finding the right product?
Explore all of our products under β-N-乙酰氨基葡萄糖苷酶检测试剂盒
仅试剂盒组分
产品编号
说明
- Dilution Buffer 8 mL
- 4-Nitrophenyl-N-acetyl-β-D-glucosaminide 50 mg
- Citrate Buffer Solution, 0.09 M 100 mL
- p-Nitrophenol Standard Solution, 10 mM 1 mL
- β-N-Acetylglucosaminidase from Jack beans 1 vial
- Sodium carbonate 5 g
signalword
Warning
hcodes
Hazard Classifications
Carc. 2 - Eye Irrit. 2 - STOT RE 2 Oral
target_organs
Liver,Kidney
wgk
WGK 3
存储类别
10 - Combustible liquids
法规信息
易制毒化学品（2类）
低风险生物材料
此项目有
商品
亚细胞组分离心分离是一种常用技术，广泛适用于多种类型的细胞和组织。由于不同细胞器的大小、形状和密度不同，因此通过离心，可从温和均质的样品中轻松分离和纯化细胞器组分。
Centrifugation separates organelles based on size, shape, and density, facilitating subcellular fractionation across various samples.
Xiaojia Liu et al.
Acta pharmaceutica Sinica. B, 11(10), 3134-3149 (2021-11-09)
Programmed cell death ligand 1 (PD-L1)/programmed cell death protein 1 (PD-1) cascade is an effective therapeutic target for immune checkpoint blockade (ICB) therapy. Targeting PD-L1/PD-1 axis by small-molecule drug is an attractive approach to enhance antitumor immunity. Using flow cytometry-based
Miguel A Lanaspa et al.
Journal of the American Society of Nephrology : JASN, 25(11), 2526-2538 (2014-05-31)
Diabetes is associated with activation of the polyol pathway, in which glucose is converted to sorbitol by aldose reductase. Previous studies focused on the role of sorbitol in mediating diabetic complications. However, in the proximal tubule, sorbitol can be converted
Xiaoting Chen et al.
Journal of cellular and molecular medicine, 23(6), 4290-4300 (2019-04-12)
Impaired autophagic degradation of intracellular lipids is causally linked to the development of non-alcoholic steatohepatitis (NASH). Pharmacological agents that can restore hepatic autophagic flux could therefore have therapeutic potentials for this increasingly prevalent disease. Herein, we investigated the effects of
全球贸易项目编号
| 货号 | GTIN |
|---|---|
| CS0780-1KT | 04061833553145 |